You are viewing an incomplete version of our website. Please click to reload the website as full version.

Aperçu des produits pour anti-PAG1 (PAG1) Anticorps

Full name:
anti-phosphoprotein Associated with Glycosphingolipid Microdomains 1 Anticorps (PAG1)
Chez www.anticorps-enligne.fr sont 97 phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1) Anticorps de 11 de différents fournisseurs disponibles. De plus, nous expédions PAG1 Protéines (4) et PAG1 Kits (3) et beaucoup plus de produits pour cette protéine. Un total de 107 PAG1 produits sont actuellement listés.
Synonymes:
8430414N03Rik, Cbp, F730007C19Rik, IGFBP-4ase, MGC80192, Pag, PAG1, PAPP-A

Tous anti-PAG1 Anticorps disponible

Vous arrivez à notre recherche pré-filtrée.

anti-PAG1 Anticorps mieux référencés

  1. Human Monoclonal PAG1 Primary Antibody pour FACS, IHC (p) - ABIN94272 : Yerly, Ding, Tauzin, van Echten-Deckert, Borisch, Hoessli: The sphingolipid-rich rafts of ALK+ lymphomas downregulate the Lyn-Cbp/PAG signalosome. dans European journal of haematology 2010 (PubMed)
    Show all 6 references for ABIN94272

  2. Human Monoclonal PAG1 Primary Antibody pour IHC (p), IP - ABIN94270 : Baumgartner, Angelisová, Setterblad, Mooney, Werling, Horejsí, Langsley: Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes. dans Blood 2003 (PubMed)
    Show all 5 references for ABIN94270

  3. Cow (Bovine) Monoclonal PAG1 Primary Antibody pour IHC (p), IP - ABIN269119 : Yamashita, Chattopadhyay, Fensterl, Zhang, Sen: A TRIF-independent branch of TLR3 signaling. dans Journal of immunology (Baltimore, Md. : 1950) 2012 (PubMed)

  4. Human Monoclonal PAG1 Primary Antibody pour FACS, IHC (p) - ABIN120652 : Brdicková, Brdicka, Andera, Spicka, Angelisová, Milgram, Horejsí: Interaction between two adapter proteins, PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. dans FEBS letters 2001 (PubMed)

Plus d’anticorps contre PAG1 partenaires d’interaction

Human phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1) interaction partners

  1. Up-regulated expression of CBP (Montrer CREBBP Anticorps) in Jurkat cells could reduce cell homogeneity and promote cell apoptosis

  2. No association Pag1 mutation with patient with Schizophrenia.

  3. The risk-associated allele of rs2370615 predisposes to allergic disease by increasing PAG1 expression, which might promote B cell activation (Montrer BLNK Anticorps) and have a pro-inflammatory effect.

  4. CBP (Montrer CREBBP Anticorps) may decrease the metastasis of esophageal carcinoma by inhibiting the activation of Src (Montrer SRC Anticorps).

  5. The inhibitory function of novobiocin in disrupting the HIF1alpha (Montrer HIF1A Anticorps)/p300 (Montrer EP300 Anticorps) complex might be important in tumor cell growth.

  6. siRNA directed against PAG1 in a radioresistant (Hep-2max) cell line dramatically enhanced the radiosensitivity and IR-induced cell death.

  7. expression of CBP (Montrer CREBBP Anticorps) gene is decreased in esophageal carcinoma, which might contribute to the tumorigenesis and progression.

  8. An over-expression of PAG1 in PC-3M-1E8 cells effectively suppresses the activation of Ras and ERK (Montrer EPHB2 Anticorps), as well as the cyclin D1 (Montrer CCND1 Anticorps) expression, leading to an inhibition of the proliferation ability of tumor cells.

  9. Cbp (Montrer CREBBP Anticorps) down-regulation is primarily mediated by epigenetic histone modifications via oncogenic MAPK (Montrer MAPK1 Anticorps)/PI3K (Montrer PIK3CA Anticorps) pathways in a subset of cancer cells.

  10. Results indicate that Cbp is required for the Csk-mediated inactivation of c-Src and may control the promotion of malignancy in NSCLC tumors that are characterized by c-Src upregulation.

Mouse (Murine) phosphoprotein Associated with Glycosphingolipid Microdomains 1 (PAG1) interaction partners

  1. STC2 (Montrer STC2 Anticorps) is involved in regulating PAPP-A (Montrer PAPPA Anticorps) activity during the development of atherosclerosis

  2. Study demonstrates proof-of-principle and provides feasibility for a novel therapeutic strategy to inhibit atherosclerotic plaque burden by selective targeting of PAPP-A (Montrer PAPPA Anticorps).

  3. stimulation of PAPP-A (Montrer PAPPA Anticorps) expression by intermittent PTH (Montrer PTH Anticorps) treatment contributes to PTH (Montrer PTH Anticorps) bone anabolism in mice

  4. PAPP-A (Montrer PAPPA Anticorps) affects fascicle structure, thereby affecting tendon phenotype.

  5. This study demonstrated that cbp (Montrer CREBBP Anticorps) increase in skeletal muscle in muscle atrophy.

  6. PAG is constitutively phosphorylated in resting T cells and rapidly dephosphorylated once the TCR is engaged.

  7. If Cbp enhances the interaction between c-Src and FAK, Cbp could promote c-Src function when lipid rafts are disrupted.

  8. PAG (Montrer PRDX1 Anticorps) can function as both a positive and a negative regulator of mast cell signaling, depending upon the signaling pathway involved. PAG (Montrer PRDX1 Anticorps) is a positive regulator of passive systemic anaphylaxis.

  9. PAPP-A (Montrer PAPPA Anticorps) has a role in development of advanced plaque with necrotic cores and buried fibrous caps (Montrer CAPS Anticorps) in the brachiocephalic artery

  10. these data indicate preferential impact of PAPP-A (Montrer PAPPA Anticorps) deficiency on visceral fat in the mouse that is associated with enhanced insulin receptor (Montrer INSR Anticorps) signaling

PAG1 profil antigène

Antigen Summary

The protein encoded by this gene is a type III transmembrane adaptor protein that binds to the tyrosine kinase csk protein. It is thought to be involved in the regulation of T cell activation.

Alternative names and synonyms associated with PAG1

  • phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) anticorps
  • phosphoprotein associated with glycosphingolipid microdomains 1 (pag1) anticorps
  • phosphoprotein associated with glycosphingolipid microdomains 1 (Pag1) anticorps
  • pregnancy-associated plasma protein A (Pappa) anticorps
  • 8430414N03Rik anticorps
  • Cbp anticorps
  • F730007C19Rik anticorps
  • IGFBP-4ase anticorps
  • MGC80192 anticorps
  • Pag anticorps
  • PAG1 anticorps
  • PAPP-A anticorps

Protein level used designations for PAG1

phosphoprotein associated with glycosphingolipid microdomains 1 , phosphoprotein associated with glycosphingolipid-enriched microdomains 1-like , Csk-binding protein , phosphoprotein associated with glycosphingolipid-enriched microdomains 1 , transmembrane adapter protein PAG , transmembrane adaptor protein PAG , transmembrane phosphoprotein Cbp , Csk binding protein , csk-binding protein , phosphoprotein transmembrane adaptor 1 , phosphoprotein-associated with GEMs , IGF-dependent IGFBP-4 protease , insulin-like growth factor-dependent IGF-binding protein 4 protease , pappalysin-1

GENE ID SPECIES
420195 Gallus gallus
446514 Xenopus laevis
464253 Pan troglodytes
610895 Canis lupus familiaris
700748 Macaca mulatta
100050548 Equus caballus
100380123 Xenopus (Silurana) tropicalis
100391406 Callithrix jacchus
100585162 Nomascus leucogenys
55824 Homo sapiens
614460 Bos taurus
64019 Rattus norvegicus
94212 Mus musculus
100157912 Sus scrofa
101112826 Ovis aries
18491 Mus musculus
Fournisseurs de qualité sélectionnés pour anti-PAG1 (PAG1) Anticorps
Avez-vous cherché autre chose?